Related Experiment Videos
Immunoscintigraphy for ocular melanoma: a reliable diagnostic technique?
K U Loeffler1, P Bräutigam, J C Simon
1Department of Ophthalmology, Freiburg University, Germany.
Summary
Immunoscintigraphy (IS) shows limited value for diagnosing ocular melanoma, with only 50% sensitivity. Antigenic differences between ocular and cutaneous melanoma likely explain this lower sensitivity.
Area of Science:
- Oncology
- Ophthalmology
- Medical Imaging
Background:
- Immunoscintigraphy (IS) is a diagnostic tool for ocular melanoma.
- Reevaluation of published data and correlation with histologic findings are needed.
Purpose of the Study:
- To reevaluate immunoscintigraphy (IS) data in patients with ocular melanoma.
- To correlate IS results with tumor histology and immunohistochemistry.
- To compare IS performance in ocular versus cutaneous melanoma.
Main Methods:
- IS performed on 35 patients with suspected ocular melanoma using 225.28S monoclonal antibody.
- Histology and immunohistochemistry (HMB-45, S-100, vimentin) analyzed in 22 cases.
- 102 patients with cutaneous melanoma served as controls.
Main Results:
- IS positive in ~50% of ocular melanoma cases; 89% sensitivity in cutaneous melanoma.
- Two false-positive results in non-melanoma cases (subretinal hemorrhage, Wegener's granulomatosis).
- No correlation between histology/immunoreactivity and IS outcome; antigenic differences noted.
Conclusions:
- IS with the 225.28S antibody has limited diagnostic value for ocular melanoma.
- Lower sensitivity in ocular melanoma is attributed to antigenic differences, not histology or technical issues.
- Further research into antigenic profiles may improve diagnostic strategies.